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Tubulin is able to switch between a straight microtubule-like
structure and a curved structure in complex with the stathmin-
like domain of the RB3 protein (T2RB3). GTP hydrolysis follow-
ing microtubule assembly induces protofilament curvature and
disassembly. The conformation of the labile tubulin het-
erodimers is unknown. One important question is whether free
GDP-tubulin dimers are straightened by GTP binding or if
GTP-tubulin is also curved and switches into a straight confor-
mation upon assembly.We have obtained insight into the bend-
ing flexibility of tubulin by analyzing the interplay of tubulin-
stathmin association with the binding of several small molecule
inhibitors to the colchicine domain at the tubulin intradimer
interface, combining structural and biochemical approaches.
The crystal structures of T2RB3 complexes with the chiral R
and S isomers of ethyl-5-amino-2-methyl-1,2-dihydro-3-phe-
nylpyrido[3,4-b]pyrazin-7-yl-carbamate, show that their bind-
ing site overlaps with colchicine ring A and that both complexes
have the same curvature as unliganded T2RB3. The binding of
these ligands is incompatible with a straight tubulin structure in
microtubules. Analytical ultracentrifugation and binding mea-
surements show that tubulin-stathmin associations (T2RB3,
T2Stath) and binding of ligands (R, S, TN-16, or the colchicine
analogue MTC) are thermodynamically independent from one
another, irrespective of tubulin being bound to GTP or GDP.
The fact that the interfacial ligands bind equally well to tubulin
dimers or stathmin complexes supports a bent conformation of
the free tubulin dimers. It is tempting to speculate that stathmin
evolved to recognize curved structures in unassembled and dis-
assembling tubulin, thus regulating microtubule assembly.
Microtubules are essential for eukaryotic chromosome seg-
regation, cellular architecture and intracellular trafficking,
among other processes. Understanding microtubule dynamics,
regulation, and organization requires knowledge of the nucle-
otide-regulated assembly switch of tubulin. Microtubules are
hollow cylinders made of protofilaments of -tubulin dimers
in head to tail association, forming a pseudohelical lattice (1).
The functional assembly-disassembly cycle of a -tubulin
molecule includes activation by GTP binding at the -subunit,
polymerization into microtubules, GTP hydrolysis at the -
interdimer interface and depolymerization of GDP-tubulin,
followed by replacement byGTP. Vectorial polymerization and
GTP hydrolysis combine with tubulin structural plasticity in
microtubule dynamics (2). Depolymerizing microtubule ends
show characteristic curled protofilaments, whereas relatively
straight sheets form at growing ends (3, 4). GDP-tubulin does
not assemble into microtubules, but forms double rings (5),
which also form upon microtubule depolymerization (6) and
correspond to curved microtubule protofilaments (7, 8). The
tendency of GDP-tubulin to curve is thought to strain the
microtubule lattice, causing disassembly when the terminal cap
of GTP-bound tubulin is lost. Interestingly, remnants of the
GTP-tubulin conformation inside microtubules have report-
edly been detected by a recombinant antibody (9). Curling pro-
tofilaments and depolymerizing microtubule ends generate
pulling force. Microtubule attachment to kinetochores couples
depolymerization to chromosome segregation in mitotic spin-
dles (10).
Stathmin (11) is a cellular microtubule inhibitor (12), which
forms a tight complex with two -tubulin dimers (13),
T2Stath,5 binding along their sides and capping the -end (14).
T2Stath has been shown to be curved by electron microscopy,
and it does not polymerize into microtubules (15). RB3 is a
stathmin family protein which shares with other members the
stathmin-like domain (SLD). Stathmin is an intrinsically disor-
dered protein, and its activity is down-regulated by multiple
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phosphorylation. Proteins of the stathmin family are pivotal
microtubule regulators implicated in signal transduction and
disease (for reviews, see Refs. 11, 14).
Only two atomic structures of -tubulin are currently
known: One is GDP-tubulin in straight antiparallel protofila-
ments of two-dimensional zinc sheets stabilized by taxol (16,
17), that has been employed to construct pseudo-atomic mod-
els of microtubules, which have parallel protofilaments, from
their electron microscopy maps (18). The other is the curved
structure of two head to tail GDP-tubulin dimers in complex
with the stathmin-like domain of RB3 (RB3-SLD) (19–21),
named here T2RB3. The structure of tubulin in microtubules is
related to the straight zinc-sheet structure, since both aremade
of similar protofilaments, although the different lateral con-
tacts cause modifications. It may be asked whether the
unknown structure of labile free -tubulin dimers relates to
the straight structure or if it is bent similarly to the T2RB3
complex, and how GTP-tubulin differs from GDP-tubulin.
It was first thought that GTP would allosterically induce a
straight conformation of tubulin subunits capable of microtu-
bule assembly and that GDP would induce a curved conforma-
tion favoring disassembly. A 12 Å resolution map of tubulin-
GDP protofilament spirals has indicated different intra- and
inter-dimer curvatures, and the structure of GMPCPP-tubulin
tubes assembled at low temperatures has been interpreted in
support of a sequential model in which a conformational
change after GTP binding straightens the dimers enough for
lateral contacts to form sheets, which later close into microtu-
bules (22). However, this type of allosteric mechanism is chal-
lenged by the findings of curved T2RB3-like structures of GTP-
bound -tubulin (23) and bacterial tubulin (24), by the lack of
nucleotide-induced structural changes in the prokaryotic tubu-
lin relative FtsZ (25) and by the biochemical properties of
-tubulin indicating that its ground state in the absence of
magnesium is the curved GDP conformation (26). This evi-
dence led to the proposal that, contrary to what was previously
thought, the free GTP-tubulin dimer is curved similarly to
tubulin rings and is driven into the straight conformation by the
microtubule lattice contacts, and that the GTP -phosphate
only lowers the unfavorable free energy difference between the
curved and the straight form (27). This could take place by
allowing the flexilibity required to adopt the straight conforma-
tion driven by the lateral interactions or by enhancing the lon-
gitudinal interaction between dimers within the microtubule
lattice. The similarGDP- andGTP-bound-tubulin structures,
the identical affinity of allocolchicine for GTP- and GDP-tubu-
lin (28), and kinetic simulations have been proposed to favor
the lattice model (29). To summarize, in the allosteric model
GTP binding would induce a straighter conformation prestruc-
tured in solution for lateral interactions (30) whereas in the
lattice model (27) -tubulin adopts a microtubule incompat-
ible, curved conformation independent of the nucleotide state,
so that the conformational switch is a consequence, not a cause,
of lattice assembly (29). More recently, molecular dynamics
simulations and coarse-grained analysis have indicated curved
conformations of GDP- and GTP-bound tubulin dimers, sup-
porting the lattice model but with a tendency toward smaller
bending in GTP-tubulin than in GDP-tubulin (31). Tubulin
flexibility has also been studied with hydrogen/deuterium
exchange mass spectrometry and urea denaturation, and a
blendedmodel proposed combining allosteric effects in the free
dimer with an assembly process dominated by lattice-induced
effects (32).
Small molecule microtubule inhibitors and antitumor drugs
have been historically employed to investigate tubulin and
microtubule assembly (33, 34). The colchicine binding site was
biochemically mapped to -tubulin near the contact interface
with -tubulin in the -tubulin dimer (28, 35, 36). The 3.5 Å
resolution structure of the curved T2RB3-colchicine complex
showed the colchicine binding site at the intradimer interface,
and how colchicine binding is incompatible with the straight
conformation of tubulin in microtubules (20). MTC is similar
to colchicine but lacks the middle ring (37) and unlike colchi-
cine it binds fast and reversibly to tubulin (38); MTC has been
extensively used as a reference ligand of the colchicine binding
site (39) and as a reversible inhibitor of cellular microtubules
(40, 41).
The two chiral isomers NSC 613862-(CI980) (S) and NSC
613863 (R) (42) have antitumor activity, bind to tubulin with a
high affinity overlapping the colchicine site and powerfully
inhibit microtubule assembly in vitro (43) and in cells (44).
Interestingly, theR and S compounds bind toGTP-tubulinwith
higher affinity than to GDP-tubulin dimers, allosterically dis-
tinguishing the bound nucleotide (45). However, allocolchicine
(28) and MTC (45) have similar affinities irrespective of the
GTP- or GDP-bound nucleotide. The synthetic microtubule
inhibitor TN-16 also competes with colchicine for binding to
tubulin (46). The recent determination of the structure of
T2RB3 in complex with TN-16 has shown that this ligand over-
laps the trimethoxyphenyl ring A of colchicine and is more
deeply buried in the -tubulin subunit, thus extending the col-
chicine binding domain (21).
We reasoned that studying the interactions of ligands of the
colchicine domain with tubulin-stathmin complexes in com-
parison with tubulin dimers should give insight into the bend-
ing flexibility of the -tubulin dimer, indicating whether its
conformation is similar to straight tubulin inmicrotubules or to
curved tubulin in complex with stathmin-like proteins, and to
which degree it depends on bound GTP or GDP. In this work,
we have determined the structures of T2RB3 with bound R and
S, and have employed the R, S, MTC, and TN-16 ligands as
probes of bending at the -tubulin intradimer interface in
tubulin dimers and in complexes with stathmin and RB3-SLD,
withGTP orGDP.We show thatR and S overlapwith TN-16 in
equally curved T2RB3 complexes, and that the four probes bind
similarly to tubulin dimers and to stathmin complexes. This
indicates that unassembled dimeric tubulin is predominantly
curved and switches into the straight conformation upon
microtubule assembly.
EXPERIMENTAL PROCEDURES
Ligands—MTC was a gift from Dr. T. J. Fitzgerald (37). Its
concentration was determined spectrophotometrically with an
extinction coefficient of 17,600 M1 cm1 at 343 nm (38). NSC
613862 (CI980) (S) and NSC 613863 (R) were a gift from Dr.
G. A. Rener (42). Their concentrations were determined spec-
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trophotometrically at 374 nm with extinction coefficients of
15100 and 15400M1cm1 for the S andR compounds, respec-
tively (42). TN-16 was from CalBiochem. Ligand stock solu-
tions in dimethyl sulfoxide were stored dry at20 °C.
Protein Purification—For crystallization experiments tubu-
lin was purified from ovine brain by two cycles of polymeriza-
tion in a highmolarity buffer followed by depolymerization (47,
48). For biochemical experiments, tubulin was purified in large
scale from lamb brain by ammonium sulfate fractionation, ion
exchange chromatography and precipitation with magnesium
(33, 49). Purified tubulin was stored in liquid nitrogen and pre-
pared for use as described (45). GTP- and GDP-tubulin were
prepared as described (45). Tubulin concentration was deter-
mined spectrophotometrically at 275 nm in 6 M guanidine
hydrochloride (275 nm 109,000M1cm1) or in 0.5% sodium
dodecyl sulfate in neutral aqueous buffer (275 nm  107,000
M1cm1).
Recombinant human stathmin was purified, stored as previ-
ously described (50), weighed, and dissolved before use. Stath-
min concentration was routinely measured using a Lowry
method (DC protein assay, Bio-Rad) with BSA standard, cor-
rected by a color yield ratio stathmin/BSA of 0.84.
RB3-SLD was expressed from a pET vector introduced into
BL21(DE3) and purified as described (48) with some modifica-
tions. A 10-ml overnight preculture of bacteria transformed
with the expression vector pET-3d containing the RB3-SLD
cDNA was used to inoculate 1L of LB-medium containing
ampicillin at 37 °C. RB3-SLD expression was induced by the
addition of 0.4 mM IPTG when the A600 nm reached the 0.4 to
0.6 range. After 3 h, the culture was cooled and centrifuged (15
min, 5,000  g). Bacterial pellets were resuspended in extrac-
tion buffer (10ml per 1 g of bacteria): 20mMTris-HCl pH 8.0, 1
mMEGTA, 2mMTCEP supplementedwith a protease inhibitor
mixture, and sonicated on ice. The lysate was cleared by centri-
fugation (15 min, 10,000  g at 4 °C), the supernatant was
heated at 80 °C for 10 min and centrifuged for 15 min at
10,000  g. Optionally, 30 mM spermine was added to the
supernatant, pH readjusted to 8.0 and the solution incubated
1 h at 4 °C. The mixture was ultracentrifuged at 4 °C (1 h,
100,000  g). The resulting supernatant was loaded onto a Q
Sepharose FF or a 5 ml HiTrap Q HP anion exchange column,
which was then washed with the anion exchange chromatogra-
phy-loading buffer: 20mMTris-HCl pH 8.2, 1 mM EGTA, 2mM
TCEP. After elution with a linear 0–0.6 M NaCl gradient, the
RB3-SLD-containing fractions, identified by SDS-PAGE, were
pooled, concentrated and loaded on a Superdex 75 26/60 or
16/60 gel filtration column, which was eluted with 10 mM
HEPES-NaOH pH 7.2, 150 mM NaCl, 2 mM TCEP. RB3-SLD-
containing fractions were pooled, concentrated to10 mg/ml,
and stored at 70 °C until use. The SLD concentration was
determined either by amino acid analysis or by titration of a
known tubulin solution with the SLD on a gel filtration column
(Superose 12 10/300). Both methods gave similar results. For
the biochemical experiments the gel filtration buffer was 10mM
sodium phosphate, 100 mM NaCl, 1 mM EGTA, pH 7.0, 1 mM
DTTwas used instead of TCEP, and RB3-SLDwas spectropho-
tometrically measured in concentrated solutions employing an
extinction coefficient 280 nm  1490 M1 cm1 (1 Tyr, 0 Trp
residues).
Crystallization and X-ray Structure Determination of the R
and S Isomer-Stathmin-Tubulin Complexes—The R and S iso-
mers were added to recycled tubulin (typically in the 50–80M
concentration range) complexed with RB3-SLD (T2RB3) using
a 1.3:2 RB3-SLD:tubulin ratio. R and S were added at a 250 M
final concentration from 10 mM stock solutions in DMSO.
Complexes were concentrated to20 mg of tubulin per ml by
ultrafiltration and were either used immediately or stored at
70 °C. Crystals were obtained at 4 °C by streak seeding a 1:1
mixture of the complex and a reservoir solution consisting of 50
mM PIPES-KOH pH 7.5, 5% PEG 400, 10% ethylene glycol to
which 4–5% PEG 20K was added (48) (21). Crystals appeared
within 48 h and were harvested within a week in the well solu-
tion with ligand at 250 M concentration, they were flash-fro-
zen in the harvesting buffer supplemented with ethylene glycol
at 25% final concentration. X-ray diffraction datasets were col-
lected at 100K using a MarCCD detector at beam-line ID14–4
of the European Synchrotron Radiation Facility, Grenoble.
Tubulin:RB3-SLD-R and S complexes crystals belong to space
group P65. Diffraction data were processed using the HKL
package (51). The structure of T2RB3-colchicine (20) in which
colchicine was removed from the model was used as a starting
point for rigid-body refinement. The structures were further
refinedwith REFMACusing the TLS option (52). Initialmodels
and topology parameters for the ligands were generated using
program PRODRG (53). Rounds of refinement were alternated
with manual refitting using the cross-validated, sigma-A
weighted, phase combined 2Fo-Fc and Fo-Fc maps (54). Pro-
gress in the model refinement was evaluated by decrease in the
free R-factor. Statistics for data processing and refinement are
summarized in supplemental Table S1.We used theOprogram
(55) for structure visualization and manual rebuilding. Super-
impositions of atomic models were done either with SUPERPK
(56) or with O. Search for interactions between the ligand and
tubulin was achieved with CONTACT (54). Figures were gen-
erated with PYMOL (57), BOBSCRIPT (58) and RASTER3D
(59).
Sedimentation Velocity—The experiments were done at
40,000 rpm and 20 °C in a Beckman Optima XL-I analytical
ultracentrifuge equipped with interference and absorbance
optics, using an eight holes An50Ti rotor and 1.2 cm Epon
double-sector centerpieces. Apparent sedimentation coeffi-
cients were determined by the sedimentation coefficient distri-
bution c(s) generated by the SEDFIT program (60) All the ana-
lytical ultracentrifugation experiments were done in 20 mM
sodiumphosphate, 10MGTP, pH6.5.WhenRB3was present,
1 mM DTT was added.
Ligand Binding Measurements by Analytical Ultracentri-
fugation—Tubulin or tubulin-stathmin complex with various
concentrations of S isomer (from 0 to 25 M) were loaded into
the analytical ultracentrifuge. Sedimentation velocity experi-
ments were performed and radial absorbance data were
acquired at 375 nm to observe the ligand distribution. The
experiment was done with tubulin or 100% of tubulin-stathmin
complex (20 M tubulin and 20 M stathmin) at 20 °C.
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The sedimentation coefficient distributionC(S) generated by
the SEDFIT program (61) allowed to quantify the bound ligand
concentration by measuring the area under the sedimenting
peak and the free ligand concentration by determination of the
baseline (ligand that does not sediment). For various total
ligand concentrations, bound ligand divided by total tubulin
concentration (B) was then plotted versus free ligand [L] con-
centrations, and the binding was analyzed using the following
equations. The binding of S isomer to tubulin required a two
non-equivalent independent binding sites model in Equation 1,
B 
K1L  K2L  2K1K2L2
1  K1L  K2L  K1K2L2
(Eq. 1)
where K1, K2 are the affinity constants of the S isomer binding.
The binding of this isomer to the tubulin-stathmin complex
could be fitted by one binding site model,
B 
K1L
1 K1L
(Eq. 2)
Binding Measurements by Fluorometric Titration—Quench-
ing of the tryptophan protein fluorescence due to the interac-
tion of the R and S compounds with tubulin was employed to
measure their binding parameters. Tubulin and tubulin-stath-
min complex (2–5 M) were titrated with various concentra-
tions of R and S isomer (0.5–12 M) in 20 mM sodium phos-
phate, 0.1 mM GTP, pH 7. The fluorescence measurements
were performed with a Horiba-Jobin-Yvon Fluoromax-3 spec-
trofluorimeter with slit widths of 2/2 nm. Corrected fluores-
cence spectra were obtained by using 1 (excitation direction)
0.2 cm cells (Hellma) thermostatted at 25 °C by a circulating
water bath. Emission spectra (exc  295 nm) were collected.
The length of the light path was chosen to decrease the light
absorption by the sample at the emission and excitation direc-
tion to minimize the inner filter effect (R and S isomers have an
absorption maximum at 374 nm). After correction for this
effect, the fluorescence intensity values at 330 nm were plotted
versus R and S isomer concentrations, and the binding param-
eters fitted as described elsewhere (62). This method was also
employed to measure the TN-16 binding to GTP-and GDP-
tubulin. Tubulin (2–5M) was titrated with various concentra-
tions of TN-16 (0.5–30M) in 20mM sodium phosphate, 10M
GTP or 1 mM GDP, 5% DMSO, pH 7. 0.2 (excitation direc-
tion) 1 cmcells (emission direction)were chosen tominimize
the inner filter effect due to the absorbance of theTN-16, which
was corrected as described (62). All experiments were done in
triplicate with three independent tubulin preparations at 25 °C.
TN-16 Binding to GTP-tubulin by Differential Absorption—
Light absorption spectra were obtained with a Perkin Elmer
Lambda 800 UV/Vis spectrophotometer employing 1 cm cells
(Hellma) thermostatted at 25 °C. For each TN-16 concentra-
tion, the tubulin and TN-16 alone spectra in 20 mM sodium
phosphate, 10 MGTP, 5% DMSO, pH 7 were subtracted from
the tubulin-TN-16mixture spectra, and the differential absorp-
tion at 330 nm was plotted versus TN-16 concentration and
analyzed as in the fluorometric titrations.
RESULTS
Structures of Tubulin-RB3-SLD Complexes with R and S Iso-
mers: Mapping the Binding Site—The structures of the T2RB3
complexes with the R and S compounds (Fig. 1A) were super-
imposable to the structures of the T2RB3-colchicine complex
(20) and to unliganded T2RB3 (except for a loop of -tubulin
that lies in the colchicine site in the absence of colchicine
domain ligands (21)). This shows that binding of these ligands
does notmodify the conformation of tubulin in theT2RB3 com-
plex (21), which accommodates them without subunit or
domain displacements in the crystal. The binding sites forR and
S isomers were identified in a 4 Å Fobs-Fcalc difference electron
density map, calculated from a model in which the ligand was
missing, by positive peaks significantly higher than non attrib-
uted ones. In the case of the R isomer, these heights were 10.9 	
and 7.6 	 in the two  subunits of T2RB3, respectively, the
highest non-attributed peak height being 5.2 	; similar results
were obtained with the S-isomer. The globular shape of the
electron density (Fig. 1B) leaves some ambiguity in the orienta-
tion of the ligands. The orientation we propose is based on the
better quality of the corresponding difference map calculated
after refinement and takes into account more favorable inter-
actions with tubulin. In the two most likely orientations of the
ligands, the locations of the carbamate and phenyl groups of R
and S, which are respectively polar and hydrophobic, are
exchanged. In the orientation we propose, the carbamate nitro-
gen and carbonyl oxygen interact with polar residues of tubulin
(Fig. 1C), whereas this group would be in an essentially hydro-
phobic environment if its location was exchanged with that of
the phenyl ring. Consistent with the results of competition
experiments (43), the ligands overlap with colchicine; this
overlap is limited to the phenyl of R (or S) and to the trime-
thoxyphenyl ring of colchicine. By contrast, the electron
densities of tubulin-bound R (or S) and TN-16 (21) largely
colocalize (Fig. 1B) within the colchicine binding domain. As
a consequence, the R and S isomers aremore deeply buried in
-tubulin than colchicine and, unlike it, they do not contact
the  subunit. The tubulin subunit structure comprises three
domains, an N-terminal nucleotide-binding domain, an
intermediate domain and a C-terminal helical hairpin. The
colchicine-binding site is mostly embedded in the interme-
diate domain. The R and S isomers make fewer contacts than
colchicine with the intermediate domain while establishing
new interactions with residues belonging to  strands S5 and
S6 in the nucleotide-binding domain (Fig. 1C). When one
superimposes the N-terminal domain of -tubulin in its
straight conformation (PDB ID: 1JFF) on that of tubulin in
T2RB3-R, and compares the intermediate domains, the fol-
lowing changes are observed. In the straight structure, the
intermediate domain -sheet (strands S8 to S10) comes
closer to the H8 helix. Together with the H7 translation, this
leads to a shrinking of the colchicine domain (21). When a
ligand is bound to it, the straight conformation cannot be
accommodated because of steric clashes the ligand makes
with surrounding secondary structure elements (S8, S9, H7,
and H8).
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The Tubulin Dimer Curvature Probed with Colchicine
Domain Ligands—Colchicine (20) or the R and S ligands (see
above) bind to -tubulin at the - association interface in
T2RB3 crystals, where -tubulin is curved, but these ligands
are known not to bind to the microtubule lattice, in which
-tubulin is straight (18). To probe the unknown bending
conformation of -tubulin dimers in solution by reference to
the curved conformation of tubulin-RB3-SLD and of tubulin-
stathmin complexes (21, 15), we have employed the strategy
schematized by the simplified thermodynamic box in Fig. 2,
which contains several linked equilibria (63). Equilibria 1 and 3
are the associations of RB3-SLD or stathmin (Stath) to dimers
and liganded dimers respectively, leading to identically curved
complexes (results above). An energetically significant modifi-
cation of the dimer curvature by the binding of the ligand (see
chemical structures in Fig. 2) would result in different stathmin
association with liganded and unliganded tubulin (63) (differ-
ent observed association constants K3obs and K1obs, respec-
tively). Reactions 4 and 2 are the binding of the interfacial probe
ligand to tubulin dimers and tubulin-stathmin complexes,
respectively. Note that straight tubulin has no room to bind the
ligand (results above). Different curvatures of tubulin in dimers
and in stathmin complexes would be expected to give rise to
different apparent affinities of the ligand (K4obs and K2obs). In
one extreme case, if the tubulin dimer was straight as in micro-
tubules, the binding of the ligand or stathminwould bend tubu-
lin, resulting in K4obs  K2obs and K1obs  K3obs; in the other
extreme case, if the dimer conformation was the same as in
the stathmin complex, the bindings of stathmin and the
ligand would be independent from each other, K4obs K2obs
and K1obs  K3obs.
First of all, we examined the effects of ligands R and S on the
tubulin-RB3 complex formation and the relative amount of
ligand bound to tubulin dimers and tubulin-RB3 complexes, by
sedimentation velocity experiments. Interference optics to
detect protein and absorbance optics to detect the small ligands
were simultaneously employed. Experiments were initially per-
formedwithGTP-tubulin because if it had a different curvature
in dimers than in the stathmin complex we should detect pref-
erential binding of theR and S isomers to one of the two tubulin
forms.As shown in Fig. 3A, the-tubulin dimer sedimented at
an apparent sedimentation coefficient of 5.6 S and the T2RB3
complex at 8 S. For the RB3-SLD to tubulin ratio employed
(3.8 M RB3-SLD, 10 M tubulin), we found 50% of each peak
(which corresponds to 55% tubulin in dimers and 45% inT2RB3
complex, taking into account the 18%mass contribution of the
RB3-SLD), compatiblewith previous resultswith stathmin (13).
FIGURE 1. The binding site for R and S in tubulin. A, general view of the
T2RB3 complexwith compound R. The-subunits are inmagenta,-subunits
in green, RB3-SLD in blue, and the R compound in cyan. B, the R isomer (cyan)
is presented in its Fobs-Fcalc omitmapcontouredat 3.5 sigmas andoverlapped
with colchicine (yellow) and TN-16 (red) (PDB ID code 3N2G). At the 4 Å reso-
lution of the diffraction data, the electron densities of the R and S isomers are
very similar; the omit map corresponding to the S isomer is presented in
supplemental Fig. S1. Residues presented are in the region from residue 127
to residue 382 of the -subunit; secondary structure elements interacting
with the R isomer are in darker green. These are strands S5-S6 in the nucleo-
tide-binding domain, helix H7, loop T7 and in the intermediate domain
strands S7-S10 and helix H8. For the limits of secondary structure elements
see (69). C, R isomer binding site. The R isomer in its most likely orientation is
in cyan in the -subunit (green). Side chains of residues most likely to make
polar interactions with the carbamate moiety of R are also presented.
Tubulin Switch Probedwith Stathmin and Antitumor Drugs
31676 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 41•OCTOBER 8, 2010
 at CSIC - Centro de Investigaciones Biológicas on O
ctober 26, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
This distribution was the same irrespectively of the presence of
the S-isomer (37 M). Scanning the samples at the ligand
absorption maximum allowed measurement of the bound
ligand sedimenting with tubulin and with the T2RB3 complex,
as shown by Fig. 3B. The area under the sedimenting peaks
analyzed by the SEDFIT program (60) represents the amount of
bound ligand. The free ligand concentration was calculated
from the SEDFIT baseline, because the unbound ligand does
not significantly sediment during the experiment. 50% of the
sedimenting S isomerwas bound to tubulin and 50%was bound
toT2RB3. This experiment showed that this ligand has a similar
affinity forGTP-tubulin dimers and for T2RB3 complexes, con-
sistent with its lack of effect onT2RB3 complex formation equi-
librium, providing a first indication that both processes are
independent. In an experiment with GDP-tubulin (7 M) and
stathmin (3.12 M) we observed two peaks corresponding to
tubulin and to the stathmin-tubulin complex (7.6 S), respec-
tively, in a 40–60% proportion (45% tubulin in dimers and 55%
in T2Stath complexes) (Fig. 3C). We similarly found 44% of the
R isomer bound to tubulin and 56% to theT2Stath complex (Fig.
3D), also indicating independent binding of the ligand and
stathmin to GDP-tubulin.
The Formation of Tubulin Complexes with Stathmin and
RB3-SLD Is Independent of the Binding of Ligands at the Intrad-
imer Interface—Based on the the above indications, we titrated
tubulin with varying concentrations of RB3-SLD or stathmin,
with and without an excess of ligand, and determined the per-
cent of tubulin in the 8 S complex by sedimentation velocity.
Excess S-isomer insignificantly modified the GTP-tubulin
complex formation with RB3-SLD (Fig. 4A) or stathmin
(supplemental Fig. S2). Similar results were obtained in an
excessR isomer (37M) (supplemental Fig. S2), with TN-16 (33
M) and with the bicyclic colchicine analogue MTC (23 M),
both with RB3-SLD and stathmin in each case (not shown).
MTC is expected to bind like colchicine rings A and C, lacking
the middle ring. The titration profiles of GDP-tubulin with
stathmin were also similar with and without R isomer (Fig. 4B),
S isomer, TN-16 orMTC (not shown). In summary, none of the
four colchicine domain ligands significantly modified the for-
mation of the RB3-SLD-tubulin and stathmin-tubulin com-
plexes, irrespective of tubulin being bound to GTP or GDP.
The Affinity of Ligand Binding at the Intradimer Interface Is
Independent of Tubulin Complex Formation with Stathmin—If
the binding of stathmin or RB3-SLD to tubulin is essentially
FIGURE 2. Scheme of tubulin dimer association with stathmin or RB3-SLD (S) or into microtubules and binding of colchicine domain ligands (L) to
-tubulin at the intradimer interface. The chemical structures of the four ligands employed as probes of tubulin bending are shown.
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independent of the binding of ligands to the colchicine domain
(see above), the reciprocal should hold, the binding of these
ligands to tubulin should not be modified in the stathmin com-
plexes (Fig. 2) (63). We went further and measured the affinity
of the ligands for tubulin and tubulin in stathmin excess
(T2Stath). We first employed sedimentation velocity to mea-
sure directly the equilibrium binding affinity of the S isomer to
tubulin and the T2Stath complexes with GTP. The proteins
were titrated with increasing concentrations of ligand and the
bound and free ligand measured by scanning the ultracentri-
fuge cells (as in Fig. 3, B and D). The concentration of bound
ligand divided by total protein concentrationwas plotted versus
free ligand concentration and analyzed (“Experimental Proce-
dures”). The binding of the S isomer to tubulin (Fig. 5A), could
be fitted by a high affinity site with binding equilibrium con-
stantKa (1.3	 0.3) 106M1, plus a lower affinity bindingwith
Ka (7.0	 0.2) 103 M1. The binding to the T2Stath complex
could be fitted by the same high affinity site, withKa (1.9	 0.9)
106 M1, without the lower affinity binding site (Fig. 5B). The
low affinity bindingmay be attributed to nonspecific binding to
tubulin, which is prevented by complex formation.
The binding of R and S isomers induced a decrease of the
intrinsic tryptophan tubulin fluorescence (43, 45).We used this
property to compare the binding affinity of both isomers to the
-tubulin dimers and to theT2Stath complexes. The apparent
binding constants are summarized in Table 1 for comparison.
The S isomer bound to tubulin with a slightly higher affinity
than the R isomer, as previously shown (43, 45). The R and S
isomer affinities were not modified in the stathmin complexes.
The affinity ratios (tubulin/T2Stath) obtained for both S and R
isomers were unitary within experi-
mental error, confirming the analyt-
ical ultracentrifugation result. In
summary, the R and S isomers bind
to theGTP-tubulin dimer and to the
T2Stath complex essentially with
the same affinity.
Finally, because the R and S iso-
mers have higher affinity for GTP-
than for GDP-tubulin (Table 1) and
since TN-16 shares the same bind-
ing site in the structures of the cor-
responding T2RB3 complexes (Fig.
1B), we explored the possibility that
TN-16 could also distinguish the
two nucleotide states of tubulin.
The binding of TN-16 to GTP-tu-
bulin measured by differential
absorption spectroscopy gave one
binding site with an association
binding constant of (5	 2) 105 M1
(Fig. 6A). However, the affinity con-
stants of TN-16 for GTP-and GDP-
tubulin measured by quenching of
the intrinsic tubulin fluorescence
were (1.7	 0.5) 105 M1 and (1.9	
0.3) 105 M1, respectively (Fig. 6B).
These results show that TN-16
binds equally to GTP- and GDP-tubulin with an affinity similar
to the colchicine analogue MTC but lower than the R and S
isomers (Table 1).
DISCUSSION
The Tubulin Assembly Switch and the Role of the Nucleotide—
Tubulin switches between a straight conformation when
assembled in microtubule protofilaments (16, 18) and a curved
conformation in complexes of two tubulin dimers with stath-
min or the RB3-SLD (15, 20). One important question for the
mechanism of microtubule dynamics is whether free tubulin
dimers straighten with respect to curved GDP-tubulin by GTP
binding which pre-structures them for assembly (30), or if
GTP-tubulin is also curved and switches into a straight confor-
mation as a consequence of the assembly contacts (27) (see
Introduction).We have obtained new insight into this problem
by studying the interplay of the tubulin-RB3-SLD/stathmin
association with the binding of small molecule microtubule
inhibitors at the tubulin intradimer interface.
The structures of T2RB3 complexes with the R and S com-
pounds determined in this work show that their binding site
overlaps with TN-16 (21), that the binding of these ligands does
not induce any large structural changeswith respect to unligan-
ded T2RB3 and that binding is incompatible with the tubulin
conformation as seen in straight protofilaments. However, the
small allosteric effects of the nucleotide gamma phosphate on
the binding affinity of the R and S isomers (45) (Table 1) are
difficult to explain from the structures of the T2RB3-R and
T2RB3-S complexes at their current resolution. The fact that
TN-16 does not distinguish GTP- fromGDP-tubulin, although
FIGURE 3. Sedimentation coefficient distribution c(s) of GTP-tubulin (10 M) and RB3 (3.82 M) in a
solution containing the S isomer (37 M) detected by interference optics (A, raw data and fitting in
supplemental Fig. S2) or by absorbance of the S isomer at 375 nm (B, supplemental Fig. S3). Sedimenta-
tion velocity of GDP-tubulin (7 M) and stathmin (3.12 M) with R isomer (10 M) detected by interference
optics (C, supplemental Fig. S4) or by absorbanceof theR isomer at 375nm (D, supplemental Fig. S5). Datawere
analyzed by the Sedfit program.
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it shares the R and S isomer binding site, may be explained by
the non-identical interactions with protein residues at the
binding site of these compounds with different chemical struc-
tures, though higher resolution data would also be required to
assess the different interactions with tubulin of these co-local-
ized ligands.
We have found that the GTP-tubulin association with RB3-
SLD and the binding of theR and S ligands (see scheme in Fig. 2)
are independent of each other. Tubulin-stathmin association
measurements and binding measurements with two other
ligands, TN-16 and the colchicine analogueMTC, led to similar
findings. These four ligands of the colchicine domain bind to
tubulin at the intradimer interface, potentially interfering with
the relative orientation of the subunits. Since the structure of
tubulin in liganded and unliganded T2RB3 complexes is curved
(this work and Ref. 21) the simplest interpretation is that the
liganded and unliganded tubulin dimers are similarly curved.
The possibility that the structure of tubulin around the col-
chicine binding site would change and the ligands binding
affinity would remain the same due to compensations of per-
turbation effects appears unlikely. This strongly supports the
proposal (27) and other evidence (29, 31) suggesting that
unassembled GTP-tubulin is curved, instead of as straight as
in microtubular sheets (22) and that its structure is close to
that of tubulin in T2RB3 (20, 21). Our results do not exclude
possible GTP-induced structural changes at another zone of
the tubulin dimer.
FIGURE 4. A, GTP-tubulin titration (10 M) by RB3 analyzed by sedimentation
velocity without (F) and with (E) S isomer (37 M) at 20 °C. B, GDP-tubulin
titration (9 M) with stathmin without (F) and with (E) R isomer (10 M) at
20 °C.
FIGURE 5. Binding of the S compound to GTP-tubulin (A) and to the GTP-
T2Stath complex (B) measured by analytical ultracentrifugation. The
experiments were done at 20 °C and analyzed as described under “Experi-
mental Procedures.”
TABLE 1
Comparison of R and S isomer and TN16binding affinities toGTP- and
GDP-liganded-tubulin dimers and to tubulin-stathmin complexes
Ligand Receptor Kb 106 (M1) Ratiotubulin/T2Stath
Ratio
GTP/GDP
R GTP-tubulin 1.7	 0.3a
1.1	 0.6b
GTP-T2Stath 1.4	 0.7a 1.2	 0.2d
GDP-tubulin 0.3	 0.1a 5.6	 1.3d
0.29	 0.05b 4.0	 2.7b
S GTP-tubulin 2.4	 1.3a
2.5	 0.7b
1.3	 0.3c
GTP-T2Stath 3.1	 1.2a 1.0	 0.3d
1.9	 0.9c 0.7c
GDP-tubulin 1.5	 0.6b 1.7	 1.2b
TN-16 GTP-tubulin 0.17	 0.05a
GDP-tubulin 0.19	 0.03a 0.9	 0.4
MTC GTP-tubulin 0.32	 0.06b
GDP-tubulin 0.31	 0.07b 1.0	 0.4
a Average of three independent Kb values determined by tubulin fluorescence
quenching in this work.
b Value previously determined by fluorescence quenching (45).
c Determined from sedimentation velocity data in this work.
d Average of three independently determined ratios.
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The radius of curvature of tubulin in T2RB3 (19) is similar to
that in magnesium-induced tubulin double rings (8), also sug-
gesting that RB3-SLD binding, at most, weakly modifies the
intrinsic curvature of unassembled tubulin.GDPbinding favors
the closure step ofmagnesium-induced tubulin double ring for-
mation (5). Colchicine binding slightly enhances (28), whereas
R and S isomers slightly inhibit this ring formation (45), possi-
bly by very weak effects propagated along multiple tubulin
dimers, that are not perceptible in the stathmin complexes.
Related to our results, it was observed that stathmin only
weakly distinguishes (13), if at all, between GTP- and GDP-
tubulin dimers (64) and we find that the binding to tubulin of
stathmin and of the colchicine domain ligands are independent
of each other, both with GTP- and GDP-tubulin. Taken
together, the data favor the conclusion that GTP and GDP-
tubulin dimers are similarly curved. In this view, binding of the
nucleotide -phosphate does notmarkedlymodify tubulin cur-
vature, but it lowers the unfavorable free energy difference
between curved soluble tubulin and straight microtubular
tubulin, and nucleotide hydrolysis in microtubules triggers the
disassembly switch (27).
The Linkages between Stathmin andAntitumorDrug Binding
to Tubulin—The association of tubulin with the cellular inhib-
itor stathmin and the binding of small molecule microtubule
inhibitors at each of the tubulin dimer interfaces are interesting
cases of heterotropic linkage (63). Ligands of the vinblastine
domain bind as wedges at the interdimer tubulin interface in
T2RB3 (65) and induce self-association of tubulin dimers lead-
ing to spirals (66) or single rings (67, 68). Their curvature radii
are compatible with the formation of tubulin complexes with
the long C-terminal -helix of SLDs (15, 65). This suggests that
vinblastine binding does not strongly modify the interdimer
curvature observed in these complexes. Because both stathmin
and vinblastine promote the end-to-end association of tubulin
dimers by binding to different sites, the linkage of the binding
equilibria results in vinblastine increasing the affinity of stath-
min for tubulin 50-fold and vice versa, which may explain the
increased sensitivity to Vinca alkaloids of tumor cells overex-
pressing stathmin (50).
We have shown here that both stathmin and four colchicine
domain ligands recognize, by binding at different sites, a simi-
larly bent conformation of tubulin in its ground state (26),
which is incompatible withmicrotubules. In this case, the bind-
ing of the colchicine domain ligands and stathmin are inde-
pendent, because ligand binding at the intradimer interface
does not affect tubulin curvature and is unrelated to the end-to
end association of tubulin dimers.
Antitumor microtubule inhibitors bind to unassembled
tubulin and to microtubule ends, suppressing microtubule
dynamics (34). Stathmin inhibits microtubule assembly by
sequestering tubulin dimers and stimulates depolymerization
at microtubule ends (14). It is tempting to speculate that pro-
teins of the stathmin family co-evolved with tubulin to recog-
nize the inactive curved conformations of unassembled anddis-
assembling tubulin and in this manner regulate microtubules.
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SUPPLEMENTAL DATA – Barbier P., et al. 2010 J. Biol. Chem. 
 
Supplementary Table S1: Statistics for Data Collection and Refinement 
 T2RB3-R isomer T2RB3-S isomer 
Data collection statistics   
data collection wavelength (Å) 0.935 0.935 
cell dimension (a(=b), c) (Å) 328.6, 54.7 326.3 , 54.1 
resolution range (Å) 30-4.0 30-4.0 
no. of unique reflections 29143 28503 
Redundancy 4.0 (2.4)a 4.5 (4.1)a
completeness (%)  98.2 (94.2)a 99.6 (99.7)a
I/σI 22 (2.4)a 20 (2.6)a
Rmergeb  0.059 (0.443)a 0.078 (0.621)a
 
Refinement statistics   
resolution range (Å) 20-4.0 20-4.0 
Rcrystc 0.209 0.223 
Rfreec 0.241 0.250 
r.m.s.d. from ideal geometry   
     bond length (Å) 0.017 0.017 
     bond angles (deg) 1.807  1.817 
a Values in parentheses correspond to the highest-resolution shell (4.1-4.0 Å). b Rmerge = ΣΣj |Ij(hkl) - 
<I(hkl)>|/ΣΣj|<I(hkl)>|, where Ij is the intensity measurement for reflection j and <I> is the mean intensity 
over j reflections. c Rcryst (Rfree) = Σ||Fobs(hkl)| - |Fcalc(hkl)||/Σ|Fobs(hkl)|, where Fobs and Fcalc are observed 
and calculated structure factors, respectively. Five percent of the reflections were excluded from the 
refinement and used to calculate Rfree. 
 
Supplementary Figure S1: The S isomer (cyan) in its Fobs-Fcalc omit map contoured at 3.5 sigmas.  
tubulin residues are presented as in Figure 1A. (PDB ID code 3N2K). 
 
Supplementary Figure S2: Sedimentation profiles (dotted line) and fitted data (solid line) of the 
c(s) analysis shown Fig. 3A (maximum entropy regularization with P = 0.68). Time-independent 
and radial-independent noise contributions initially estimated from the standard c(s) analysis of 
the whole profiles were subtracted from the interference data. For clarity, only one of each third 
sedimentation profile is shown. Radial residuals (difference between the experimental data and 
the fitted data for each point) are shown superimposed in a graph at the bottom panel (units of 
the corresponding signal, fringes or absorbance). 
 
Supplementary Figure S3: Sedimentation profiles (dots) and fitted data (solid line) of the c(s) 
analysis shown Fig. 3B. 
 
Supplementary Figure S4: Sedimentation profiles (dotted line) and fitted data (solid line) of the 
c(s) analysis shown Fig. 3C 
 
Supplementary Figure S5: Sedimentation profiles (dots) and fitted data (solid line) of the c(s) 
analysis shown Fig. 3D. 
 
Supplementary Figure S6: Titration of GTP-tubulin (10 M) with Stathmin analyzed by 
sedimentation velocity without () and with (●) S isomer and () R isomer (37 µM) at 20°C.   
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